Pulmonary interstitial lymphography: A prospective trial with potential impact on stereotactic ablative radiotherapy planning for early-stage lung cancer

Ryan B. Ko, Jonathan A. Abelson, Dominik Fleischmann, John D. Louie, Gloria L. Hwang, Daniel Y. Sze, Emil Schüler, Kayla N. Kielar, Peter G. Maxim, Quynh Thu Le, Wendy H. Hara, Maximilian Diehn, Nishita Kothary, Billy W. Loo

Research output: Contribution to journalArticlepeer-review

Abstract

This prospective feasibility trial investigated pulmonary interstitial lymphography to identify thoracic primary nodal drainage (PND). A post-hoc analysis of nodal recurrences was compared with PND for patients with early-stage lung cancer; larger studies are needed to establish correlation. Exploratory PND-inclusive stereotactic ablative radiotherapy plans were assessed for dosimetric feasibility.

Original languageEnglish (US)
Article number110079
JournalRadiotherapy and Oncology
Volume191
DOIs
StatePublished - Feb 2024

Keywords

  • Lung cancer
  • Lymphography
  • Primary nodal drainage
  • Regional recurrence
  • Sentinel lymph node
  • Stereotactic ablative radiotherapy
  • Stereotactic body radiation therapy

ASJC Scopus subject areas

  • Hematology
  • Oncology
  • Radiology Nuclear Medicine and imaging

Fingerprint

Dive into the research topics of 'Pulmonary interstitial lymphography: A prospective trial with potential impact on stereotactic ablative radiotherapy planning for early-stage lung cancer'. Together they form a unique fingerprint.

Cite this